Colossal raises $200M to bring back the woolly mammoth
De-extinction startup Colossal BioSciences just secured $200M in fresh funding, lifting its valuation to a massive $10.2 billion. The company will use the capital to push forward genetic engineering for the woolly mammoth, thylacine, and dodo, with tech aimed at species preservation and human healthcare.